- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/00 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patent holdings for IPC class C07D 233/00
Total number of patents in this class: 133
10-year publication summary
|
8
|
3
|
4
|
4
|
2
|
2
|
2
|
3
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arkema France | 4242 |
5 |
| Novartis AG | 10262 |
4 |
| Bristol-myers Squibb Company | 4742 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Boehringer Ingelheim International GmbH | 4493 |
2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 58 |
2 |
| Allergan, Inc. | 2167 |
2 |
| Takeda Pharmaceutical Company Limited | 2712 |
2 |
| Antecip Bioventures II LLC | 374 |
2 |
| Kyushu University, National University Corporation | 1715 |
2 |
| PGI Drug Discovery LLC | 33 |
2 |
| Sumitomo Riko Company Limited | 1139 |
2 |
| Sunovion Pharmaceuticals Inc. | 244 |
2 |
| (chan-n) Changzhou Green Photosensitive Materials Co., Ltd. | 6 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| 3m Innovative Properties Company | 17478 |
1 |
| BASF SE | 21303 |
1 |
| Janssen Pharmaceutica N.V. | 3168 |
1 |
| Centre National de La Recherche Scientifique | 11023 |
1 |
| Bayer MaterialScience AG | 711 |
1 |
| Other owners | 92 |